Panacea Life Sciences Holdings, Inc. (PLSH) stock
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Panacea Life Sciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Panacea Life Sciences's operating cash flow for the twelve months ending Mar 31, 2024 was -$1.57M. For fiscal 2023 it was -$1.52M. The highest annual figure on record is -$399.65K in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$1.52M | – |
| FY2022 | Dec 31, 2022 | -$2.40M | – |
| FY2021 | Dec 31, 2021 | -$3.92M | – |
| FY2020 | Dec 31, 2020 | -$7.65M | – |
| FY2019 | Dec 31, 2019 | -$5.75M | – |
| FY2018 | Dec 31, 2018 | -$465.76K | – |
| FY2017 | Dec 31, 2017 | -$1.23M | – |
| FY2016 | Dec 31, 2016 | -$890.96K | – |
| FY2015 | Dec 31, 2015 | -$640.02K | – |
| FY2014 | Dec 31, 2014 | -$399.65K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2024 | Mar 31, 2024 | -$357.09K | – |
| Q4 FY2023 | Dec 31, 2023 | $1.57K | – |
| Q3 FY2023 | Sep 30, 2023 | -$728.87K | – |
| Q2 FY2023 | Jun 30, 2023 | -$483.32K | – |
| Q1 FY2023 | Mar 31, 2023 | -$313.85K | – |
| Q4 FY2022 | Dec 31, 2022 | -$523.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$711.08K | – |
| Q2 FY2022 | Jun 30, 2022 | -$729.46K | – |
| Q1 FY2022 | Mar 31, 2022 | -$436.04K | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.23M | – |
| Q3 FY2021 | Sep 30, 2021 | -$752.50K | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.14M | – |
| Q1 FY2021 | Mar 31, 2021 | -$795.23K | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.03M | – |
| Q3 FY2020 | Sep 30, 2020 | -$600.35K | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.85M | – |
| Q1 FY2020 | Mar 31, 2020 | -$164.28K | – |
| Q4 FY2019 | Dec 31, 2019 | -$718.62K | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.54M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.65M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.83M | – |
| Q4 FY2018 | Dec 31, 2018 | -$57.83K | – |
| Q3 FY2018 | Sep 30, 2018 | -$73.92K | – |
| Q2 FY2018 | Jun 30, 2018 | -$38.73K | – |
| Q1 FY2018 | Mar 31, 2018 | -$295.28K | – |
| Q4 FY2017 | Dec 31, 2017 | -$30.80K | – |
| Q3 FY2017 | Sep 30, 2017 | -$93.89K | – |
| Q2 FY2017 | Jun 30, 2017 | -$326.80K | – |
| Q1 FY2017 | Mar 31, 2017 | -$783.43K | – |
| Q4 FY2016 | Dec 31, 2016 | -$406.82K | – |
| Q3 FY2016 | Sep 30, 2016 | -$129.28K | – |
| Q2 FY2016 | Jun 30, 2016 | -$188.32K | – |
| Q1 FY2016 | Mar 31, 2016 | -$166.54K | – |
| Q4 FY2015 | Dec 31, 2015 | -$69.14K | – |
| Q1 FY2015 | Mar 31, 2015 | -$81.16K | – |
| Q4 FY2014 | Dec 31, 2014 | -$289.52K | – |
| Q3 FY2014 | Sep 30, 2014 | -$15.13K | – |
See a number that looks wrong?